CIDRAP newsletters options
Though early-hit nations are on the downslope of their Omicron surges, others are battling rising cases.
Steps include launching a US international pandemic preparedness project and appointing a global health security envoy.
The US Department of Agriculture (USDA) on Jan 14 announced that highly pathogenic H5N1 avian influenza was detected in a wild wigeon in South Carolina, marking the first time the Eurasian strain of the virus has been detected in the United States since 2016.
The finding follows the recent detection of high-path H5N1 in wild birds and poultry in Canada's Newfoundland and Labrador region.
Today a study from Germany published in Science shows three doses of the Pfizer-BioNTech COVID-19 vaccine raised antibody levels against the highly transmissible Omicron (B.1.1.529) variant.
After battling foreign fluctuations, Nexus Pharmaceuticals bucks convention and builds local.
Poor birth outcomes occurred even in women who weren't severely ill with COVID-19.
Cases are falling in Cleveland; Newark, New Jersey; Washington, DC; and New York state.
A randomized clinical trial found that fosfomycin did not demonstrate noninferiority to comparator antibiotics for bacteremic urinary tract infections (bUTIs) caused by multidrug-resistant (MDR) Escherichia coli, but it could remain an option for select patients, researchers reported yesterday in JAMA Network Open.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Needless insurer spending on ivermectin prescriptions for COVID-19, estimated at $2.5 million in the United States for the week of Aug 13, 2021—the most recent week analyzed—would extrapolate to $130 million annually, US researchers reported yesterday in JAMA.
In 1 of the 3 studies, vaccination was 98% protective against ICU stay and life support in teens.
The Court allowed a mandate for workers at federally funded healthcare facilities.
Yet 80% of low-risk newborns got antibiotics, and for similar durations as high-risk infants.
India's cases have spiked 30-fold in a month, fueled by the highly transmissible Omicron variant.
Danish microbiome technology company SNIPR Biome ApS announced this week that the US Food and Drug Administration has approved the company's application to initiate the first human clinical trial of its CRISPR-based drug for preventing Escherichia coli infections in cancer patients.
Austrian scientists writing in a letter in the New England Journal of Medicine yesterday demonstrate poor neutralization of the Omicron variant when using serum from vaccinated or recovered COVID-19 patients, potentially signaling a need for variant-specific vaccines.
The steps are part of continued efforts to keep schools open for in-person learning.
Risk factors were older age, chronic conditions, and longer symptoms.
"Almost 50,000 deaths a week is 50,000 deaths too many," says WHO head.
The US COVID-19 vaccination program may have averted 14 million infections, saved more than 240,000 lives, and prevented upwards of 1.1 million hospitalizations in the first half of 2021, according to estimates from a modeling study yesterday in JAMA Network Open.
